BIO CEO: Application to Present

September 28, 2011

[View]

The aim of the 14th Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies and investors to foster the development of important new medicines that will expand the industry’s pipeline. With this mission, companies exclusively developing medical devices or services will not be considered.

Companies that meet the stated criteria should FULLY complete the application form below.

Only the Company Description and Therapeutic Area of Focus may be used in conference materials. The rest of the information below is used for selection purposes only and will not be printed in conference handbooks, or as profiles for the partnering system.

Name of Company: *

Address Line 1: *

Address Line 2:

City: *

State: *

Zip: *

Country: *

Website: *

Primary Contact Name: *

Primary Contact Title: *

Primary Contact Email: *

Primary Contact Phone:

Company Twitter Handle:

Company CEO and/or Top Company Official:

Ownership: *

Most Recent Round of Funding Completed: *

For Private Companies
All Fields Required. Enter N/A if Public Company

Total Amount Raised To-Date: *

For Private Companies
All Fields Required. Enter N/A if Public Company

Previous and Current Investors:

List up to 10

Exhange: *

For Public Companies
All Fields Required. Enter N/A if Private Company

Ticker: *

For Public Companies
All Fields Required. Enter N/A if Private Company

I acknowledge that my Company Description may be used on BIO’s websites and conference materials.: *

Yes

Company Description: *

Please provide a 2-3 sentence description about your company. Longer submissions will be edited.

Presentation Objective: *

2,000 Characters or Less

Therapeutic Area(s) of Focus: *

Technology & Current Research:

2,000 characters or less

Partnership Strategy, Current Alliances, & Recent Milestones :

2,000 characters or less

Additional Information:

Who referred you to this application?: *

BIO CEO: Application to Present

Join Us: